Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution

Purpose. Published data about cryotherapy for prostate cancer (PC) treatment are based on case series with a lack of clinical trials and the inexistence of a validated definition of biochemical failure. A prospective study with standardized followup protocol was conducted in our institution. Materia...

Full description

Bibliographic Details
Main Authors: S. Alvarez Rodríguez, F. Arias Fúnez, C. Bueno Bravo, R. Rodríguez-Patrón Rodríguez, E. Sanz Mayayo, V. Hevia Palacios, F. J. Burgos Revilla
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2014/571576
id doaj-786c697f313f4ca0ad5ee4dd5a6805c5
record_format Article
spelling doaj-786c697f313f4ca0ad5ee4dd5a6805c52020-11-24T23:58:10ZengHindawi LimitedProstate Cancer2090-31112090-312X2014-01-01201410.1155/2014/571576571576Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single InstitutionS. Alvarez Rodríguez0F. Arias Fúnez1C. Bueno Bravo2R. Rodríguez-Patrón Rodríguez3E. Sanz Mayayo4V. Hevia Palacios5F. J. Burgos Revilla6Urology Department, Ramón y Cajal Hospital, University of Alcalá de Henares, Colmenar km 9,100, 28034 Madrid, SpainUrology Department, Ramón y Cajal Hospital, University of Alcalá de Henares, Colmenar km 9,100, 28034 Madrid, SpainUrology Department, Ramón y Cajal Hospital, University of Alcalá de Henares, Colmenar km 9,100, 28034 Madrid, SpainUrology Department, Ramón y Cajal Hospital, University of Alcalá de Henares, Colmenar km 9,100, 28034 Madrid, SpainUrology Department, Ramón y Cajal Hospital, University of Alcalá de Henares, Colmenar km 9,100, 28034 Madrid, SpainUrology Department, Ramón y Cajal Hospital, University of Alcalá de Henares, Colmenar km 9,100, 28034 Madrid, SpainUrology Department, Ramón y Cajal Hospital, University of Alcalá de Henares, Colmenar km 9,100, 28034 Madrid, SpainPurpose. Published data about cryotherapy for prostate cancer (PC) treatment are based on case series with a lack of clinical trials and the inexistence of a validated definition of biochemical failure. A prospective study with standardized followup protocol was conducted in our institution. Material and Methods. Prospective study of a series of cases including 108 patients diagnosed with localized PC at clinical stage T1c-T2c treated by primary cryoablation and median followup of 61 months. Criteria of biochemical recurrence were unified according to the American Society for Therapeutic Radiology and Oncology (ASTRO). End points were biochemical progression-free survival (BPFS), cancer-specific survival, and overall survival. Rate of complications was reported. Results. The BPFS for low-, medium-, and high-risk patients was 96.4%, 91.2%, and 62.2%, respectively. Cancer-specific survival was 98.1%. Overall survival reached 94.4%. Complications included incontinence in 5.6%, urinary tract obstruction in 1.9%, urethral sloughing in 5.6%, haematuria in 1.9%, perineal pain in 11.1%, and prostatorectal fistula in 0.9%. Erectile disfunction was found in 98.1%. Conclusions. Cryotherapy is an effective and minimally invasive treatment for primary PC in well-selected cases, with low surgical risk and good results in terms of BPFS, cancer-specific survival, and overall survival.http://dx.doi.org/10.1155/2014/571576
collection DOAJ
language English
format Article
sources DOAJ
author S. Alvarez Rodríguez
F. Arias Fúnez
C. Bueno Bravo
R. Rodríguez-Patrón Rodríguez
E. Sanz Mayayo
V. Hevia Palacios
F. J. Burgos Revilla
spellingShingle S. Alvarez Rodríguez
F. Arias Fúnez
C. Bueno Bravo
R. Rodríguez-Patrón Rodríguez
E. Sanz Mayayo
V. Hevia Palacios
F. J. Burgos Revilla
Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution
Prostate Cancer
author_facet S. Alvarez Rodríguez
F. Arias Fúnez
C. Bueno Bravo
R. Rodríguez-Patrón Rodríguez
E. Sanz Mayayo
V. Hevia Palacios
F. J. Burgos Revilla
author_sort S. Alvarez Rodríguez
title Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution
title_short Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution
title_full Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution
title_fullStr Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution
title_full_unstemmed Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution
title_sort cryotherapy for primary treatment of prostate cancer: intermediate term results of a prospective study from a single institution
publisher Hindawi Limited
series Prostate Cancer
issn 2090-3111
2090-312X
publishDate 2014-01-01
description Purpose. Published data about cryotherapy for prostate cancer (PC) treatment are based on case series with a lack of clinical trials and the inexistence of a validated definition of biochemical failure. A prospective study with standardized followup protocol was conducted in our institution. Material and Methods. Prospective study of a series of cases including 108 patients diagnosed with localized PC at clinical stage T1c-T2c treated by primary cryoablation and median followup of 61 months. Criteria of biochemical recurrence were unified according to the American Society for Therapeutic Radiology and Oncology (ASTRO). End points were biochemical progression-free survival (BPFS), cancer-specific survival, and overall survival. Rate of complications was reported. Results. The BPFS for low-, medium-, and high-risk patients was 96.4%, 91.2%, and 62.2%, respectively. Cancer-specific survival was 98.1%. Overall survival reached 94.4%. Complications included incontinence in 5.6%, urinary tract obstruction in 1.9%, urethral sloughing in 5.6%, haematuria in 1.9%, perineal pain in 11.1%, and prostatorectal fistula in 0.9%. Erectile disfunction was found in 98.1%. Conclusions. Cryotherapy is an effective and minimally invasive treatment for primary PC in well-selected cases, with low surgical risk and good results in terms of BPFS, cancer-specific survival, and overall survival.
url http://dx.doi.org/10.1155/2014/571576
work_keys_str_mv AT salvarezrodriguez cryotherapyforprimarytreatmentofprostatecancerintermediatetermresultsofaprospectivestudyfromasingleinstitution
AT fariasfunez cryotherapyforprimarytreatmentofprostatecancerintermediatetermresultsofaprospectivestudyfromasingleinstitution
AT cbuenobravo cryotherapyforprimarytreatmentofprostatecancerintermediatetermresultsofaprospectivestudyfromasingleinstitution
AT rrodriguezpatronrodriguez cryotherapyforprimarytreatmentofprostatecancerintermediatetermresultsofaprospectivestudyfromasingleinstitution
AT esanzmayayo cryotherapyforprimarytreatmentofprostatecancerintermediatetermresultsofaprospectivestudyfromasingleinstitution
AT vheviapalacios cryotherapyforprimarytreatmentofprostatecancerintermediatetermresultsofaprospectivestudyfromasingleinstitution
AT fjburgosrevilla cryotherapyforprimarytreatmentofprostatecancerintermediatetermresultsofaprospectivestudyfromasingleinstitution
_version_ 1725451506641010688